WO2000049410A3 - Procedes et dispositifs d'isolation et d'analyse de la teneur proteique des cellules - Google Patents
Procedes et dispositifs d'isolation et d'analyse de la teneur proteique des cellules Download PDFInfo
- Publication number
- WO2000049410A3 WO2000049410A3 PCT/US2000/004023 US0004023W WO0049410A3 WO 2000049410 A3 WO2000049410 A3 WO 2000049410A3 US 0004023 W US0004023 W US 0004023W WO 0049410 A3 WO0049410 A3 WO 0049410A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- protein
- analysis
- methods
- normal
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 238000004458 analytical method Methods 0.000 title abstract 3
- 230000001413 cellular effect Effects 0.000 title 1
- 238000000370 laser capture micro-dissection Methods 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 7
- 238000000034 method Methods 0.000 abstract 4
- 230000003211 malignant effect Effects 0.000 abstract 2
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 abstract 2
- 238000000672 surface-enhanced laser desorption--ionisation Methods 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000001502 gel electrophoresis Methods 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 238000011835 investigation Methods 0.000 abstract 1
- 238000005040 ion trap Methods 0.000 abstract 1
- 238000004811 liquid chromatography Methods 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 230000002250 progressing effect Effects 0.000 abstract 1
- 238000000575 proteomic method Methods 0.000 abstract 1
- 238000004611 spectroscopical analysis Methods 0.000 abstract 1
- 238000001262 western blot Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/2813—Producing thin layers of samples on a substrate, e.g. smearing, spinning-on
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/2813—Producing thin layers of samples on a substrate, e.g. smearing, spinning-on
- G01N2001/2833—Collecting samples on a sticky, tacky, adhesive surface
- G01N2001/284—Collecting samples on a sticky, tacky, adhesive surface using local activation of adhesive, i.e. Laser Capture Microdissection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU33671/00A AU772680B2 (en) | 1999-02-16 | 2000-02-16 | LCM (Laser capture microdissection) for cellular protein analysis |
US09/913,667 US6969614B1 (en) | 1999-02-16 | 2000-02-16 | Methods for the isolation and analysis of cellular protein content |
JP2000600101A JP2002537561A (ja) | 1999-02-16 | 2000-02-16 | 細胞タンパク質成分を単離および分析するための方法および装置 |
EP00911845A EP1153300A2 (fr) | 1999-02-16 | 2000-02-16 | Procedes et dispositifs d'isolation et d'analyse de la teneur proteique des cellules |
CA002359649A CA2359649A1 (fr) | 1999-02-16 | 2000-02-16 | Procedes et dispositifs d'isolation et d'analyse de la teneur proteique des cellules |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12028899P | 1999-02-16 | 1999-02-16 | |
US60/120,288 | 1999-02-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000049410A2 WO2000049410A2 (fr) | 2000-08-24 |
WO2000049410A3 true WO2000049410A3 (fr) | 2001-03-08 |
WO2000049410A9 WO2000049410A9 (fr) | 2001-08-30 |
Family
ID=22389357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/004023 WO2000049410A2 (fr) | 1999-02-16 | 2000-02-16 | Procedes et dispositifs d'isolation et d'analyse de la teneur proteique des cellules |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1153300A2 (fr) |
JP (1) | JP2002537561A (fr) |
AU (1) | AU772680B2 (fr) |
CA (1) | CA2359649A1 (fr) |
WO (1) | WO2000049410A2 (fr) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001234880A1 (en) * | 2000-02-08 | 2001-08-20 | The Regents Of The University Of Michigan | Mapping of differential display of proteins |
CN1426536A (zh) * | 2000-03-20 | 2003-06-25 | 东弗吉尼亚医学院 | 前列腺癌标记 |
AU2001269877A1 (en) | 2000-06-19 | 2002-01-02 | Correlogic Systems, Inc. | Heuristic method of classification |
SG144731A1 (en) | 2000-07-18 | 2008-08-28 | Correlogic Systems Inc | A process for discriminating between biological states based on hidden patterns from biological data |
DE10043470B4 (de) | 2000-09-04 | 2006-01-19 | Mpb Meltec Patent- Und Beteiligungsgesellschaft Mbh | Verfahren zur Identifizierung von zellspezifischen Proteinen |
WO2002068695A2 (fr) * | 2001-02-22 | 2002-09-06 | Arcturus Engineering, Inc. | Immunohistochimie quantitative (qihc) |
US7049397B2 (en) * | 2001-04-30 | 2006-05-23 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons |
US6627607B2 (en) * | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons |
US20020160417A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons |
US20040198950A1 (en) | 2001-04-30 | 2004-10-07 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons |
US6617308B2 (en) * | 2001-04-30 | 2003-09-09 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons |
US20020160533A1 (en) | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons |
US20020160532A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons |
US6620786B2 (en) * | 2001-04-30 | 2003-09-16 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having molecular weight of 2937 daltons |
US6599877B2 (en) * | 2001-04-30 | 2003-07-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons |
US20030040602A1 (en) * | 2001-04-30 | 2003-02-27 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1406 daltons |
US20020160423A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1536 daltons |
US6890763B2 (en) * | 2001-04-30 | 2005-05-10 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons |
US6602855B2 (en) * | 2001-04-30 | 2003-08-05 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons |
US7087435B2 (en) * | 2001-04-30 | 2006-08-08 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons |
US6693080B2 (en) * | 2001-04-30 | 2004-02-17 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons |
US6756476B2 (en) | 2001-04-30 | 2004-06-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons |
US20020160418A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1949 daltons |
US6627606B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons |
US20040224423A1 (en) * | 2001-04-30 | 2004-11-11 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons |
US6677303B2 (en) | 2001-04-30 | 2004-01-13 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons |
US6627608B2 (en) * | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons |
US20020160434A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1777 daltons |
US20020160420A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Process for diagnosis of physiological conditions by characterization of proteomic materials |
US7294688B2 (en) | 2001-04-30 | 2007-11-13 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons |
US6620787B2 (en) * | 2001-04-30 | 2003-09-16 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons |
US6593298B2 (en) * | 2001-04-30 | 2003-07-15 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons |
US7008800B2 (en) | 2001-04-30 | 2006-03-07 | Artemis Proteomics, Ltd. | Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons |
US6703366B2 (en) * | 2001-04-30 | 2004-03-09 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons |
US7314717B2 (en) | 2001-04-30 | 2008-01-01 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons |
US20020160421A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Method for monitoring and validating stress induction of disease state |
US6998243B2 (en) | 2001-04-30 | 2006-02-14 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons |
US7314762B2 (en) * | 2001-11-21 | 2008-01-01 | Nanogen, Inc. | Apolipoprotein biopolymer markers indicative of insulin resistance |
JP2005510716A (ja) * | 2001-11-23 | 2005-04-21 | シン.クス ファーマ、インコーポレイテッド | インスリン耐性を示すグロビンバイオポリマーマーカー |
US7097989B2 (en) * | 2001-11-23 | 2006-08-29 | Syn X Pharma, Inc. | Complement C3 precursor biopolymer markers predictive of type II diabetes |
US20090093000A1 (en) * | 2001-11-23 | 2009-04-09 | George Jackowski | Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease |
US20070003974A1 (en) * | 2001-11-23 | 2007-01-04 | George Jackowski | Cene-E biopolymer marker indicative of age matched control |
US7125678B2 (en) * | 2001-11-23 | 2006-10-24 | Nanogen, Inc. | Protein biopolymer markers predictive of type II diabetes |
US20030113808A1 (en) * | 2001-12-13 | 2003-06-19 | George Jackowski | Apolipoprotein biopolymer markers predictive of alzheimers disease |
AU2003304161A1 (en) | 2002-07-29 | 2005-01-21 | Correlogic Systems, Inc. | Quality assurance/quality control for high throughput bioassay process |
SE0202346D0 (sv) * | 2002-07-30 | 2002-07-30 | Astrazeneca Ab | Profiling process |
US7695752B2 (en) | 2003-01-24 | 2010-04-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target activated microtransfer |
WO2004068104A2 (fr) | 2003-01-24 | 2004-08-12 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Microtransfert active d'un element cible |
US8168568B1 (en) | 2003-03-10 | 2012-05-01 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Combinatorial therapy for protein signaling diseases |
US20050124965A1 (en) * | 2003-12-08 | 2005-06-09 | Becton, Dickinson And Company | Phosphatase inhibitor sample collection system |
CA2548842A1 (fr) | 2003-12-11 | 2005-07-07 | Correlogic Systems, Inc. | Procede de diagnostic d'etats biologiques mettant en oeuvre un modele adaptateur centralise, et un traitement a distance d'echantillons |
US8962302B2 (en) | 2005-11-07 | 2015-02-24 | Canon Kabushiki Kaisha | Biological tissue processing substrate for fixing proteins or protein degradation products in tissue for analysis |
KR101065571B1 (ko) * | 2006-09-28 | 2011-09-19 | 가부시키가이샤 시마즈세이사쿠쇼 | 파라핀 포매 표본의 탈파라핀법 및 파라핀 포매 표본의 해석법 |
MY150234A (en) | 2007-06-29 | 2013-12-31 | Ahn Gook Pharmaceutical Company Ltd | Predictive markers for ovarian cancer |
CN102471748B (zh) | 2007-11-02 | 2014-03-26 | 株式会社Humanix | 伴随细胞观察采集细胞液和成分分析法以及采集细胞液·分析装置 |
US9502227B2 (en) | 2007-11-02 | 2016-11-22 | Humanix Co., Ltd. | Capturing of cell fluid and analysis of its components under observation of cells and instruments for the cell fluid capturing and the analysis |
EP2309262A1 (fr) * | 2009-10-06 | 2011-04-13 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Procédé pour la quantification de biomolécules |
CN102621301B (zh) * | 2011-01-28 | 2014-10-08 | 上海铭源数康生物芯片有限公司 | 一种基于硝酸纤维素膜的蛋白芯片封闭液的制备方法 |
WO2015199976A1 (fr) | 2014-06-24 | 2015-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Microdissection activée par une cible |
CN106644632B (zh) * | 2016-11-17 | 2019-08-27 | 中国科学院苏州生物医学工程技术研究所 | 用于单层细胞平铺的人工基质 |
CN113740544A (zh) * | 2021-07-29 | 2021-12-03 | 山东第一医科大学(山东省医学科学院) | 鉴定人垂体组织泌乳激素蛋白质存在形式生物标志物方法 |
WO2023250212A1 (fr) * | 2022-06-24 | 2023-12-28 | The Johns Hopkins Univeristy | Systèmes de microdissection d'expression |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61275221A (ja) * | 1985-05-30 | 1986-12-05 | Mitsui Pharmaceut Inc | タンパク質 |
US4976957A (en) * | 1974-03-12 | 1990-12-11 | Samuel Bogoch | Process for the production of recognins and their chemoreciprocals |
US5843657A (en) * | 1994-03-01 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation of cellular material under microscopic visualization |
-
2000
- 2000-02-16 CA CA002359649A patent/CA2359649A1/fr not_active Abandoned
- 2000-02-16 WO PCT/US2000/004023 patent/WO2000049410A2/fr not_active Application Discontinuation
- 2000-02-16 EP EP00911845A patent/EP1153300A2/fr not_active Withdrawn
- 2000-02-16 AU AU33671/00A patent/AU772680B2/en not_active Ceased
- 2000-02-16 JP JP2000600101A patent/JP2002537561A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4976957A (en) * | 1974-03-12 | 1990-12-11 | Samuel Bogoch | Process for the production of recognins and their chemoreciprocals |
JPS61275221A (ja) * | 1985-05-30 | 1986-12-05 | Mitsui Pharmaceut Inc | タンパク質 |
US5843657A (en) * | 1994-03-01 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation of cellular material under microscopic visualization |
Non-Patent Citations (7)
Title |
---|
BANKS ROSAMONDE E; DUNN MICHAEL J ET AL.: "The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis - Preliminary findings", ELECTROPHORESIS, vol. 20, April 1999 (1999-04-01) - May 1999 (1999-05-01), pages 689 - 700, XP000925546 * |
CAZARES L H; GONG L; NASIM S; SCHELLMAMMER P F; WRIGHT G L JR: "Discovery of prostate cancer biomarkers from laser capture microdissected (LCM) cells using innovative ProteinChipTM SELDI mass spectroscopy", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING (91ST ANNUAL MEETING, SAN FRANCISCO, CALIFORNIA, USA; APRIL 01-05, 2000), March 2000 (2000-03-01), pages 851, XP000929268 * |
DATABASE WPI Week 198703, Derwent World Patents Index; AN 1987-017788, XP002143852, NOGUCHI JUJI ET AL.: "Protein from animal cerebral nerve tumour cell ..." * |
EMMERT-BUCK M R; ORNSTEIN D K; GILLESPIE J W; PAWELETZ C P; VOCKE C D; ET AL.: "Protein fingerprinting of LCM-dissected human esophageal and prostate cancer by 2D-PAGE", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING (90TH ANNUAL MEETING, PHILADELPHIA, PENNSYLVANIA, USA; APRIL 10-14, 1999), vol. 40, no. 526, March 1999 (1999-03-01), pages 526, XP000929253 * |
EMMERT-BUCK MICHAEL R; GILLESPIE JOHN W ET AL.: "An approach to proteomic analysis of human tumors", MOLECULAR CARCINOGENESIS, vol. 27, March 2000 (2000-03-01), pages 158 - 165, XP000925515 * |
SIMONE N L ET AL: "Laser-capture microdissection: opening the microscopic frontier to molecular analysis", TRENDS IN GENETICS,NL,ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, vol. 14, no. 7, 1 July 1998 (1998-07-01), pages 272 - 276, XP004124689, ISSN: 0168-9525 * |
SIMONE N L; REMALEY A T; PETRICOIN E F; GLICKMAN J W; BONNER R; EMMERT-BUCK M R; FLEISCHER T A; LIOTTA L A: "PSA quantitation in prostate cancer tissue cells procured by laser capture microdissection", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING (90TH ANNUAL MEETING, PHILADELPHIA, PENNSYLVANIA, USA; APRIL 10-14, 1999), vol. 40, March 1999 (1999-03-01), pages 411, XP000929252 * |
Also Published As
Publication number | Publication date |
---|---|
AU3367100A (en) | 2000-09-04 |
EP1153300A2 (fr) | 2001-11-14 |
WO2000049410A2 (fr) | 2000-08-24 |
JP2002537561A (ja) | 2002-11-05 |
WO2000049410A9 (fr) | 2001-08-30 |
AU772680B2 (en) | 2004-05-06 |
CA2359649A1 (fr) | 2000-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000049410A3 (fr) | Procedes et dispositifs d'isolation et d'analyse de la teneur proteique des cellules | |
Chaurand et al. | Profiling proteins from azoxymethane‐induced colon tumors at the molecular level by matrix‐assisted laser desorption/ionization mass spectrometry | |
Stutz | Advances in the analysis of proteins and peptides by capillary electrophoresis with matrix‐assisted laser desorption/ionization and electrospray‐mass spectrometry detection | |
Liu et al. | On-line dual microdialysis with ESI-MS for direct analysis of complex biological samples and microorganism lysates | |
WO2004042072A3 (fr) | Analyse quantitative d'isoformes de proteines utilisant la spectrometrie de masse a temps de vol par desorption/ionisation laser assistee par matrice | |
US11199547B2 (en) | Methods and systems for LC-MS/MS proteomic genotyping | |
WO2005123959A3 (fr) | Detection d'analysat par essais a multiplexage | |
CA2467144A1 (fr) | Systeme pour l'analyse de melanges complexes de fluides biologiques et autres pour obtenir des donnees sur l'etat biologique | |
Bhattacharya et al. | Laser capture microdissection MALDI for direct analysis of archival tissue | |
WO2006062471B1 (fr) | Procedes et interfaces de separations simples et multidimensionnelles, aux fins de caracterisation et/ou d'identification de molecules par spectrometrie de masse | |
WO2004038752A3 (fr) | Sources d'electronebulisation a capillaires contigus et dispositif analytique | |
Chiu et al. | Desalting paper spray mass spectrometry (DPS-MS) for rapid detection of glycans and glycoconjugates | |
WO2004050845A3 (fr) | Methodes de quantification et d'identification de peptides et de proteines | |
Zhang et al. | Membrane-assisted capillary isoelectric focusing coupling with matrix-assisted laser desorption/ionization-Fourier transform mass spectrometry for neuropeptide analysis | |
O’Neil et al. | Profiling the progression of cancer: separation of microsomal proteins in MCF10 breast epithelial cell lines using nonporous chromatophoresis | |
CA2554575A1 (fr) | Preparation de fluides d'origine biologique pour la determination de biomarqueurs par spectrometrie de masse | |
Chen et al. | Rapid identification and screening of proteins from whole cell lysates of human erythroleukemia cells in the liquid phase, using non‐porous reversed phase high‐performance liquid chromatography separations of proteins followed by multi‐assisted laser desorption/ionization mass spectrometry analysis and sequence database searching | |
Chen et al. | Device for the reversed-phase separation and on-target deposition of peptides incorporating a hydrophobic sample barrier for matrix-assisted laser desorption/ionization mass spectrometry | |
US20210333291A1 (en) | AUTOMATIC SAMPLE WORKFLOW FOR LC-MS BASED HbA1c MEASUREMENT ON INTACT PROTEIN LEVEL | |
Fernandez-Lima et al. | Ion mobility-mass spectrometer interface for collisional activation of mobility separated ions | |
Zhu et al. | Use of two-dimensional liquid fractionation for separation of proteins from cell lysates without the presence of methionine oxidation | |
Klenø et al. | MALDI MS peptide mapping performance by in-gel digestion on a probe with prestructured sample supports | |
Casado | Proteomics for nasal secretion analysis | |
Tummala et al. | Effect of sodium dodecyl sulfate micelles on peptide mass fingerprinting by matrix‐assisted laser desorption/ionization mass spectrometry | |
Santos et al. | Separation and Analysis of Intact Prostate Specific Antigen (PSA) and its Proteoforms by CESI-MS Under Native and Denaturing Conditions. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 33671/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2359649 Country of ref document: CA Ref country code: CA Ref document number: 2359649 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 600101 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/22-22/22, DRAWINGS, REPLACED BY NEW PAGES 1/22-22/22 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000911845 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000911845 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09913667 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 33671/00 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000911845 Country of ref document: EP |